{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02307",
      "entity_text" : "RU486",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with Rg1 (2 and 4 mg/kg) and RU486 significantly alleviated the histological changes, increased the expression of MAP2, and attenuated the neuronal injury in the frontal cortex and hippocampus CA1 and CA3.",
  "reading_complete" : "2020-08-02T14:37:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:36:29Z",
  "trigger" : "attenuated",
  "evidence" : [ "RU486 significantly alleviated the histological changes, increased the expression of MAP2, and attenuated the neuronal injury" ],
  "pmc_id" : "5593467",
  "score" : 0
}